BGS649

DRUG3 trials

Sponsors

Mereo BioPharma

Conditions

Hypogonadotropic HypogonadismPelvic Pain Associated With Refractory Endometriosis

Phase 2

A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis

TerminatedNCT01116440

Mereo BioPharmaPelvic Pain Associated With Refractory Endometriosis

Start: 2010-04-15End: 2012-03-21Updated: 2020-11-23

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

CompletedNCT02730169

Mereo BioPharmaHypogonadotropic Hypogonadism

Start: 2016-05-12End: 2018-05-19Updated: 2022-09-14

A 6 Month Safety Extension Study of MBGS205

CompletedNCT02908074

Mereo BioPharmaHypogonadotropic Hypogonadism

Start: 2016-11-15End: 2018-11-21Updated: 2023-05-18

Related Papers

Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial

European Journal of Endocrinology2023-08-1113 citations

OR18-4 Beneficial Effect on Sperm Production of Leflutrozole in Men with Obesity-Associated Secondary Hypogonadotropic Hypogonadism: Results from a Phase II Study

Journal of the Endocrine Society2019-04-011 citations